CLINICAL TRIALS PROFILE FOR RIBAVARIN
✉ Email this page to a colleague
All Clinical Trials for Ribavarin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00502970 ↗ | Short Course of Interferon Treatment in Patients With HCV Infection | Completed | Getz Pharma | Phase 4 | 2004-05-01 | To determine if a shorter course of interferon and ribavirin therapy will be sufficient in carefully selected patients with chronic hepatitis C virus genotype 3 infection, as compared to the standard length of treatment of 6 months. |
NCT00502970 ↗ | Short Course of Interferon Treatment in Patients With HCV Infection | Completed | Aga Khan University | Phase 4 | 2004-05-01 | To determine if a shorter course of interferon and ribavirin therapy will be sufficient in carefully selected patients with chronic hepatitis C virus genotype 3 infection, as compared to the standard length of treatment of 6 months. |
NCT00703872 ↗ | HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients | Unknown status | Hepasome Pharmaceuticals | Phase 2 | 2008-05-01 | A Phase II, Open Label, Multi-Center, Proof-Of-Concept Study determing whether treatment with HDV-Interferon (HDV-IFN), by oral or subcutaneous (injection) routes, and ribavirin results in similar efficacy [Rapid Virologic Response (RVR)] and safety as the reported efficacy and safety with pegylated alpha-interferon-2a and ribavirin (historical control) in patients with chronic hepatitis C (treatment naïve by oral route and non-responders by SC route respectively). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ribavarin
Condition Name
Clinical Trial Locations for Ribavarin
Trials by Country
Clinical Trial Progress for Ribavarin
Clinical Trial Phase
Clinical Trial Sponsors for Ribavarin
Sponsor Name